FDAJune 11, 2025device

ASPRIRE Cristalle Mammography System (cleared under K212873) installed with the ASPIRE Cristalle Digital Breast Tomosynthesis (DBT) Option (approved under P160031).

Official recall recorded by the U.S. Food & Drug Administration.

The hazard

Devices had an unapproved slabbing software function enabled for use.

What to do

FDA enforcement status: Ongoing

Brands named

fujifilm healthcare americasfujifilmfujifilm healthcare

UPCs

01547410297546045474102945460454741029457604547410297546045741029754561707017672132417070176721325

Recall history

Other federal recalls tied to the same brand — a factual pattern, straight from the source data.

Own something like this?

AllClear screens your whole list against every CPSC, FDA, USDA and NHTSA recall — and tells you the day a new one names something you own.

Start free — 200 items, no card →